These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9344167)

  • 1. Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: a crossover study with melatonin.
    Bénès L; Claustrat B; Horrière F; Geoffriau M; Konsil J; Parrott KA; DeGrande G; McQuinn RL; Ayres JW
    J Pharm Sci; 1997 Oct; 86(10):1115-9. PubMed ID: 9344167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary evaluation of transdermal delivery of melatonin in human subjects.
    Lee BJ; Parrott KA; Ayres JW; Sack RL
    Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):337-46. PubMed ID: 7827808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an oral pulsatile delivery system for melatonin in humans.
    Hoffmann H; Dittgen M; Hoffmann A; Bartsch C; Breitbarth H; Timpe C; Farker K; Schmidt U; Mellinger U; Zimmermann H; Gräser T; Oettel M
    Pharmazie; 1998 Jul; 53(7):462-6. PubMed ID: 9699222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems.
    Priano L; Esposti D; Esposti R; Castagna G; De Medici C; Fraschini F; Gasco MR; Mauro A
    J Nanosci Nanotechnol; 2007 Oct; 7(10):3596-601. PubMed ID: 18330178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral melatonin administration on sex hormone, prolactin, and thyroid hormone concentrations in adult dogs.
    Ashley PF; Frank LA; Schmeitzel LP; Bailey EM; Oliver JW
    J Am Vet Med Assoc; 1999 Oct; 215(8):1111-5. PubMed ID: 10530323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
    Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
    Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin responses to clonidine and yohimbine challenges.
    Kennedy SH; Gnam W; Ralevski E; Brown GM
    J Psychiatry Neurosci; 1995 Jul; 20(4):297-304. PubMed ID: 7647083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes.
    Dubey V; Mishra D; Asthana A; Jain NK
    Biomaterials; 2006 Jun; 27(18):3491-6. PubMed ID: 16513163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oramucosal delivery of LHRH: pharmacokinetic studies of controlled and enhanced transmucosal permeation.
    Nakane S; Kakumoto M; Yukimatsu K; Chien YW
    Pharm Dev Technol; 1996 Oct; 1(3):251-9. PubMed ID: 9552307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin.
    Gupta SK; Sathyan G
    J Clin Pharmacol; 1999 Mar; 39(3):289-96. PubMed ID: 10073329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects.
    Cardot JM; Chaumont C; Dubray C; Costantini D; Aiache JM
    Br J Clin Pharmacol; 2004 Oct; 58(4):345-51. PubMed ID: 15373926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indomethacin kinetics and urinary excretion of prostaglandin E2 following oral administration of various dosage forms of indomethacin].
    Düsing R; Dittrich P; Kukovetz WR; Lehmann K; Kramer HJ
    Z Rheumatol; 1983; 42(4):235-41. PubMed ID: 6580789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
    Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin and its precursor L-tryptophan prevent acute gastric mucosal damage induced by aspirin in humans.
    Konturek PC; Celinski K; Slomka M; Cichoz-Lach H; Burnat G; Naegel A; Bielanski W; Konturek JW; Konturek SJ
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():67-75. PubMed ID: 18812629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral melatonin reduces blood coagulation activity: a placebo-controlled study in healthy young men.
    Wirtz PH; Spillmann M; Bärtschi C; Ehlert U; von Känel R
    J Pineal Res; 2008 Mar; 44(2):127-33. PubMed ID: 18289163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.